vs
HORIZON BANCORP INC（HBNC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
HORIZON BANCORP INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.8倍（$63.5M vs $35.5M），HORIZON BANCORP INC净利率更高（42.4% vs -304.2%，领先346.7%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 19.5%），HORIZON BANCORP INC自由现金流更多（$74.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 9.2%）
第一地平线集团（原第一田纳西银行）是一家金融服务企业，1864年成立，总部位于美国田纳西州孟菲斯。集团通过旗下银行子公司第一地平线银行，在美国东南部12个州开展金融业务，是该区域第四大区域性银行。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
HBNC vs RXRX — 直观对比
营收规模更大
HBNC
是对方的1.8倍
$35.5M
营收增速更快
RXRX
高出662.3%
19.5%
净利率更高
HBNC
高出346.7%
-304.2%
自由现金流更多
HBNC
多$121.6M
$-47.3M
两年增速更快
RXRX
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.5M | $35.5M |
| 净利润 | $26.9M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 51.5% | -304.8% |
| 净利率 | 42.4% | -304.2% |
| 营收同比 | 19.5% | 681.7% |
| 净利润同比 | 347.4% | 39.6% |
| 每股收益（稀释后） | $0.44 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HBNCRXRX
| Q4 25 | $63.5M | $35.5M | ||
| Q3 25 | $58.4M | $5.2M | ||
| Q2 25 | $66.3M | $19.2M | ||
| Q1 25 | $68.8M | $14.7M | ||
| Q4 24 | $53.1M | $4.5M | ||
| Q3 24 | $58.4M | $26.1M | ||
| Q2 24 | $55.8M | $14.4M | ||
| Q1 24 | $53.2M | $13.8M |
净利润HBNCRXRX
| Q4 25 | $26.9M | $-108.1M | ||
| Q3 25 | $-222.0M | $-162.3M | ||
| Q2 25 | $20.6M | $-171.9M | ||
| Q1 25 | $23.9M | $-202.5M | ||
| Q4 24 | $-10.9M | $-178.9M | ||
| Q3 24 | $18.2M | $-95.8M | ||
| Q2 24 | $14.1M | $-97.5M | ||
| Q1 24 | $14.0M | $-91.4M |
毛利率HBNCRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率HBNCRXRX
| Q4 25 | 51.5% | -304.8% | ||
| Q3 25 | -490.4% | -3327.6% | ||
| Q2 25 | 36.8% | -916.8% | ||
| Q1 25 | 40.8% | -1297.9% | ||
| Q4 24 | -41.3% | -4042.4% | ||
| Q3 24 | 31.0% | -377.1% | ||
| Q2 24 | 28.5% | -697.4% | ||
| Q1 24 | 28.8% | -698.4% |
净利率HBNCRXRX
| Q4 25 | 42.4% | -304.2% | ||
| Q3 25 | -380.2% | -3135.3% | ||
| Q2 25 | 31.1% | -894.2% | ||
| Q1 25 | 34.8% | -1373.3% | ||
| Q4 24 | -20.5% | -3935.5% | ||
| Q3 24 | 31.1% | -367.5% | ||
| Q2 24 | 25.4% | -676.6% | ||
| Q1 24 | 26.3% | -662.4% |
每股收益（稀释后）HBNCRXRX
| Q4 25 | $0.44 | $-0.17 | ||
| Q3 25 | $-4.69 | $-0.36 | ||
| Q2 25 | $0.47 | $-0.41 | ||
| Q1 25 | $0.54 | $-0.50 | ||
| Q4 24 | $-0.25 | $-0.56 | ||
| Q3 24 | $0.41 | $-0.34 | ||
| Q2 24 | $0.32 | $-0.40 | ||
| Q1 24 | $0.32 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $139.5M | $743.3M |
| 总债务越低越好 | $248.6M | $9.6M |
| 股东权益账面价值 | $688.3M | $1.1B |
| 总资产 | $6.4B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.36× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资HBNCRXRX
| Q4 25 | $139.5M | $743.3M | ||
| Q3 25 | $458.3M | $659.8M | ||
| Q2 25 | $137.9M | $525.1M | ||
| Q1 25 | $169.7M | $500.5M | ||
| Q4 24 | $293.4M | $594.4M | ||
| Q3 24 | $234.8M | $427.6M | ||
| Q2 24 | $146.1M | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务HBNCRXRX
| Q4 25 | $248.6M | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $1.2B | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益HBNCRXRX
| Q4 25 | $688.3M | $1.1B | ||
| Q3 25 | $660.8M | $1.0B | ||
| Q2 25 | $790.9M | $919.1M | ||
| Q1 25 | $776.1M | $933.9M | ||
| Q4 24 | $763.6M | $1.0B | ||
| Q3 24 | $754.8M | $524.6M | ||
| Q2 24 | $726.7M | $584.4M | ||
| Q1 24 | $721.3M | $401.2M |
总资产HBNCRXRX
| Q4 25 | $6.4B | $1.5B | ||
| Q3 25 | $6.7B | $1.4B | ||
| Q2 25 | $7.7B | $1.3B | ||
| Q1 25 | $7.6B | $1.3B | ||
| Q4 24 | $7.8B | $1.4B | ||
| Q3 24 | $7.9B | $726.5M | ||
| Q2 24 | $7.9B | $775.9M | ||
| Q1 24 | $7.9B | $557.8M |
负债/权益比HBNCRXRX
| Q4 25 | 0.36× | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | 1.61× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $79.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $74.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | 117.0% | -133.1% |
| 资本支出强度资本支出/营收 | 7.8% | 3.5% |
| 现金转化率经营现金流/净利润 | 2.94× | — |
| 过去12个月自由现金流最近4个季度 | $115.9M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流HBNCRXRX
| Q4 25 | $79.2M | $-46.1M | ||
| Q3 25 | $10.9M | $-117.4M | ||
| Q2 25 | $19.5M | $-76.4M | ||
| Q1 25 | $15.2M | $-132.0M | ||
| Q4 24 | $6.4M | $-115.4M | ||
| Q3 24 | $32.3M | $-59.2M | ||
| Q2 24 | $15.9M | $-82.2M | ||
| Q1 24 | $6.5M | $-102.3M |
自由现金流HBNCRXRX
| Q4 25 | $74.3M | $-47.3M | ||
| Q3 25 | $9.4M | $-117.6M | ||
| Q2 25 | $18.1M | $-79.6M | ||
| Q1 25 | $14.1M | $-133.8M | ||
| Q4 24 | $1.3M | $-116.7M | ||
| Q3 24 | $31.0M | $-63.8M | ||
| Q2 24 | $15.1M | $-83.4M | ||
| Q1 24 | $5.4M | $-109.0M |
自由现金流率HBNCRXRX
| Q4 25 | 117.0% | -133.1% | ||
| Q3 25 | 16.1% | -2272.5% | ||
| Q2 25 | 27.3% | -413.9% | ||
| Q1 25 | 20.5% | -907.4% | ||
| Q4 24 | 2.4% | -2567.7% | ||
| Q3 24 | 53.1% | -244.6% | ||
| Q2 24 | 27.1% | -578.5% | ||
| Q1 24 | 10.1% | -789.9% |
资本支出强度HBNCRXRX
| Q4 25 | 7.8% | 3.5% | ||
| Q3 25 | 2.6% | 4.7% | ||
| Q2 25 | 2.1% | 16.4% | ||
| Q1 25 | 1.6% | 12.4% | ||
| Q4 24 | 9.6% | 28.6% | ||
| Q3 24 | 2.2% | 17.5% | ||
| Q2 24 | 1.5% | 8.2% | ||
| Q1 24 | 2.2% | 48.2% |
现金转化率HBNCRXRX
| Q4 25 | 2.94× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.94× | — | ||
| Q1 25 | 0.64× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.78× | — | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 0.47× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
